PDS Biotechnology Corp (NAS:PDSB) Stock News, Headlines & Updates
PDS Biotechnology Corp Stock News from GuruFocus
- 1
Jun 12, 2024
PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in Head and Neck Cancer
Marketwired • 7:00am
May 15, 2024
PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
Marketwired • 7:00am
May 09, 2024
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
Marketwired • 5:00pm
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
GlobeNewswire • 5:00pm
PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
Marketwired • 7:00am
May 07, 2024
PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024
Marketwired • 7:00am
May 03, 2024
PDS Biotechnology Announces Details of Virtual KOL Event
Marketwired • 7:00am
May 02, 2024
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news